InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Audet Juliette Berangere. Director active across 1 company, notably NewAmsterdam Pharma Co N.V.. Cumulatively, 2 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €16k. History available since 26 September 2024. The latest transaction was filed on 26 September 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations